Image

Rehabilitation Following Reverse Total Shoulder Arthroplasty

Rehabilitation Following Reverse Total Shoulder Arthroplasty

Recruiting
55 years and older
All
Phase N/A

Powered by AI

Overview

Reverse total shoulder arthroplasty (RTSA) has been successful in patients with rotator cuff arthropathy, proximal humerus fractures, failed primary total shoulder arthroplasty or failed hemiarthroplasty, and massive irreparable rotator cuff tear. Patients who undergo an RTSA report pain relief and functional range of motion. It has been more than 20 years since the advent of the RTSA construct but an immediate post-operative rehabilitation with active shoulder range of motion has not been prospectively studied in comparison to the traditional post-operative rehabilitation highlighted by Boudreau et al.12 Investigators plan to prospectively follow our patients following RTSA undergoing an immediate active shoulder rehabilitation (IASR) vs traditional rehabilitation in a randomized controlled fashion. Investigators plan to document clinical outcomes, complications and cost effectiveness out to 1 year.

The study will hopefully fulfill the Triple Aim model for HealthPartners by improving the health of the population, improve the experience of each individual, and make healthcare affordable by decreasing the total cost of care.

Eligibility

Inclusion Criteria:

  • > 55 years of age.
  • Candidate for a primary reverse total shoulder arthroplasty.
  • Capable of completing self-administered questionnaires.
  • Be willing and able to return for all study-related follow-up procedures.
  • Able and willing to give informed consent.
  • Proficient in the English language.

Exclusion Criteria:

In-Clinic:

  • Patients planning on undergoing a Primary Reverse Shoulder Total Arthroplasty due to proximal humeral fracture.
  • Previous shoulder surgery including previous total shoulder arthroplasty or reverse total shoulder arthroplasty or hemiarthroplasty, or instability repairs
  • Active bacterial infection of the shoulder.
  • Any concomitant shoulder procedure.
  • Additional ipsilateral or contralateral upper limb pathology that requires active treatment (i.e. surgery or brace).
  • Inflammatory arthropathy.
  • Diagnosed with Rheumatoid arthritis
  • Diagnosed with gout.
  • Subject is on chronic anticoagulation due to a bleeding disorder or has taken anticoagulants within 10 days prior to surgery.
  • Peripheral vascular disease or other vascular disorders that would impair healing.
  • Peripheral neuropathy or other neurological disorders that may impair the patient to ambulate.
  • Patient is on workers compensation.
  • Any condition requiring chemotherapy.
  • Active tobacco user or former tobacco user who is not free of using tobacco for 8 weeks.
  • Uncontrolled Diabetes Mellitus with an HbA1C > 7.5%.
  • Current drug or alcohol abuse.
  • Major medical illness (life expectancy less then 2 years or unacceptably high operative risk)
  • Suspicion of cervical radiculopathy or myelopathy.
  • Deltoid insufficiency on physical examination.

Intra-operative:

• Iatrogenic glenoid fracture

Post-operative:

  • Neurological injury of the upper extremity.
  • Complications from Primary Reverse Shoulder Total Arthroplasty (i.e. post-operative infection, bleeding, hardware failure).

Study details
    Shoulder Osteoarthritis

NCT03804853

HealthPartners Institute

18 June 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.